4:["$","div",null,{"className":"min-h-screen bg-white flex flex-col","children":[["$","div",null,{"className":"px-6 pt-6 pb-4 border-b border-gray-100","children":[["$","div",null,{"className":"flex items-center gap-1.5 text-xs text-gray-400 mb-4","children":[["$","a",null,{"href":"/","className":"hover:text-[#26a69a] transition-colors","children":"Market"}],["$","span",null,{"children":"›"}],["$","span",null,{"className":"text-gray-600","children":"Leonard Schleifer"}]]}],["$","div",null,{"className":"text-[10px] text-gray-400 uppercase tracking-widest mb-1","children":"Company Profile"}],["$","h1",null,{"className":"text-2xl font-bold text-gray-900","children":"Leonard Schleifer"}],null]}],["$","div",null,{"className":"flex-1 px-6 py-6","children":[["$","p",null,{"className":"text-sm text-gray-600 leading-relaxed mb-8","children":"Leonard S. Schleifer is an American businessman and is the co-founder and chief executive of the biotechnology company Regeneron Pharmaceuticals."}],["$","div",null,{"className":"columns-1 md:columns-2 gap-10","children":[["$","div","0",{"className":"mb-8 break-inside-avoid","children":[["$","div",null,{"className":"text-xs font-semibold text-gray-400 uppercase tracking-wide mb-3 border-b border-gray-100 pb-1","children":"Early life and education"}],["$","div",null,{"className":"text-sm text-gray-600 leading-relaxed wiki-content","dangerouslySetInnerHTML":{"__html":"He was born and raised in a Jewish family, the son of Florence and Charles Baker Schleifer, in Queens, New York. His father was a sweater manufacturer and World War II codebreaker. He graduated with a B.S. from Cornell University and a MD-PhD from the University of Virginia where he studied under future Nobel Laureate, Alfred G. Gilman. He then worked at New York Hospital where he trained to become a neurologist and also served as a junior faculty member. ==Career=="}}]]}],["$","div","1",{"className":"mb-8 break-inside-avoid","children":[["$","div",null,{"className":"text-xs font-semibold text-gray-400 uppercase tracking-wide mb-3 border-b border-gray-100 pb-1","children":"Career"}],["$","div",null,{"className":"text-sm text-gray-600 leading-relaxed wiki-content","dangerouslySetInnerHTML":{"__html":"Noticing that the biotechnology company Genentech was conducting state-of-the-art research but not on diseases of the nervous system, Schleifer was determined to get into the biotechnology business. Eylea As CEO of Regeneron, Schleifer oversaw the \"approval and growth of high-priced drugs.\" In 2011, Regeneron's first successful drug was Eylea for age-related macular degeneration. Regeneron's apparent privileged access of its experimental Covid-19 therapeutic to Donald Trump and members of the Trump administration drew criticism over ethical concerns. ==Personal life=="}}]]}],["$","div","2",{"className":"mb-8 break-inside-avoid","children":[["$","div",null,{"className":"text-xs font-semibold text-gray-400 uppercase tracking-wide mb-3 border-b border-gray-100 pb-1","children":"Personal life"}],"$Lf"]}]]}],"$L10"]}],"$L11"]}]